-- Arovella Therapeutics (ASX:ALA) said the requisitioning shareholder has withdrawn its April 8 notice, which called for a general meeting to appoint three directors, according to a Thursday Australian bourse filing.
Arovella Therapeutics had earlier said the notice "cannot be lawfully effected at a general meeting," and had invited the shareholder to formally withdraw the notice.
Its shares fell 3% in recent trading on Thursday.
EQT (EQT) has an average rating of overweight and mean price target of $70.76, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:BX delivered solid Q1 2026 results with distributable earnings of $1.36 per share, narrowly exceeding the $1.34 consensus estimate and reflecting 25% Y/Y growth led by strong net realizations of $36B across Private Equity ($15B) and Credit & Insurance ($14B). The firm demonstrated exceptional asset gathering momentum with $68.5B of inflows and total AUM reaching $1.3T (+12% Y/Y), while fee-earning AUM grew to $937.6B (+9% Y/Y). The firm is seeing successful monetization and exits from private equity-owned companies, with continued focus on fast-growing areas such as digital and energy infrastructure positioning the firm well for future growth. Credit & Insurance led AUM growth at $457.5B (+17.7% Y/Y), followed by Private Equity at $429.9B (+15.9%), while Real Estate faced headwinds at $315.3B (-2% Y/Y). We think Credit & Insurance and Private Equity will continue to lead growth and performance in 2026 from institutional demand, while Real Estate will grow modestly as market conditions improve over time.
Consumer stocks were mixed pre-bell Thursday, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) 0.3% higher and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) down 0.5%.Keurig Dr Pepper (KDP) shares were up almost 3% after the company reported Q1 adjusted earnings and revenue that topped analysts' expectations.